Alterations in regulatory regions of erm(B) genes from clinical isolates of enterococci resistant to telithromycin

Archives of Pharmacal Research

Volumn 34, Issue 12, 2011, Pages 2149-2154

  Min, Yu Hong ^a   Yoon, Eun Jeong ^b   Kwon, Ae Ran ^a   Shim, Mi Ja ^c   Choi, Eung Chil ^b  

^a Daegu Haany University   (South Korea)

^b Seoul National University   (South Korea)

^c University of Seoul   (South Korea)

Author keywords

Enterococcus faecalis; Enterococcus faecium; Erm(B); Resistance; Telithromycin

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; ERYTHROMYCIN; GENOMIC DNA; MESSENGER RNA; PROTEIN ERM; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROMOTER REGION; RNA STRUCTURE; SEQUENCE ANALYSIS; STRUCTURAL GENE; TRANSLATION INITIATION;

BASE SEQUENCE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENES, BACTERIAL; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID CONFORMATION; POINT MUTATION; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA;

EID: 84857187218     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1219-4     Document Type: Article

References (26)

1. Balfour, J. A. and Figgitt, D. P., Telithromycin. Drugs, 61, 815-829 (2001). (Pubitemid 32507017)
2. Baltch, A. L., Smith, R. P., Pitz, W. J., and Bopp, L. H., Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci. Chemotherapy, 47, 250-260 (2001). (Pubitemid 32588784)
3. Barry, A. L., Fuchs, P. C., and Brown, S. D., In vitro activities of ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob. Agents Chemother., 42, 2138-2140 (1998). (Pubitemid 28363110)
4. Bearden, D. T., Neuhauser, M. M., and Garey, K. W., Telithromycin: an oral ketolide for respiratory infections. Pharmacotherapy, 21, 1204-1222 (2001). (Pubitemid 32939095)
5. Bryskier, A., Ketolides-telithromycin, an example of a new class of antibacterial agents. Clin. Microbiol. Infect., 6, 661-669 (2000). (Pubitemid 34966092)
6. Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A7. CLSI, Wayne, PA, U.S.A., (2007).
7. Hisanaga, T., Hoban, D. J., and Zhanel, G. G., Mechanisms of resistanceto telithromycin in Streptococcus pneumoniae. J. Antimicrob. Chemother., 56, 447-450 (2005). (Pubitemid 41264118)
8. Jalava, J., Kataja, J., Seppälä, H., and Huovinen, P., In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob. Agents Chemother., 45, 789-793 (2001). (Pubitemid 32182027)
9. Leclercq, R. and Courvalin, P., Resistance to macrolides and related antibiotics in Streptococcus pneumonia. Antimicrob. Agents Chemother., 46, 2727-2734 (2002).
10. Lim, J.-A., Kwon, A.-R., Kim, S.-K., Chong, Y., Lee, K., and Choi, E.-C., Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital. J. Antimicrob. Chemother., 49, 489-495 (2002). (Pubitemid 34223670)
11. Malbruny, B., Nagai, K., Coquemont, M., Bozdogan, B., Andrasevic, A. T., Hupkova, H., Leclercq, R., and Appelbaum, P. C., Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J. Antimicrob. Chemother., 49, 935-939 (2002). (Pubitemid 34692887)
12. Min, Y.-H., Jeong, J.-H., Choi, Y.-J., Yun, H.-J., Lee, K., Shim, M.-J., Kwak, J.-H., and Choi, E.-C., Heterogeneity of macrolide-lincosamide- streptogramin B resistance phenotypes in enterococci. Antimicrob. Agents Chemother., 47, 3415-3420 (2003). (Pubitemid 37345698)
13. Min, Y.-H., Kwon, A.-R., Yoon, E.-J., Shim, M.-J., and Choi, E.-C., Translational attenuation and mRNA stabilization as mechanisms of erm(B) induction by erythromycin. Antimicrob. Agents Chemother., 52, 1782-1789 (2008). (Pubitemid 351614672)
14. Morosini, M.-I., Cantón, R., Loza, E., del Campo, R., Almaraz, F., and Baquero, F., Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. J. Antimicrob. Chemother., 52, 50-55 (2003). (Pubitemid 36850084)
15. Nagai, K., Appelbaum, P. C., Davies, T. A., Kelly, L. M., Hoellman, D. B., Andrasevic, A. T., Drukalska, L., Hryniewicz, W., Jacobs, M. R., Kolman, J., Miciuleviciene, J., Pana, M., Setchanova, L., Thege, M. K., Hupkova, H., Trupl, J., and Urbaskova P., Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrob. Agents Chemother., 46, 546-549 (2002). (Pubitemid 34087213)
16. Okamoto, H., Miyazaki, S., Tateda, K., Ishii, Y., and Yamaguchi, K., Comparative in vitro activity of telithromycin (HMR3647), three macrolides, amoxicillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan. J. Antimicrob. Chemother., 46, 797-802 (2000).
17. Reinert, R. R., Lütticken, R., Bryskier, A., and Al-Lahham, A., Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob. Agents Chemother., 47, 489-493 (2003). (Pubitemid 36158071)
18. Rosato, A., Vicarini, H., Bonnefoy, A., Chantot, J. F., and Leclercq, R., A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin A. Antimicrob. Agents Chemother., 42, 1392-1396 (1998). (Pubitemid 28257638)
19. Rosato, A., Vicarini, H., and Leclercq, R., Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J. Antimicrob. Chemother., 43, 559-562 (1999). (Pubitemid 29182307)
20. Singh, K. V., Malathum, K., and Murray, B. E., In vitro activities of a new ketolide, ABT-773, against multidrugresistant gram-positive cocci. Antimicrob. Agents Chemother., 45, 3640-3643 (2001). (Pubitemid 33107897)
21. Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., and Sutcliffe, J., Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother., 44, 2118-2125 (2000). (Pubitemid 30484435)
22. Van Bambeke, F., Harms, J. M., Laethem, Y. V., and Tulkens, P. M., Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections. Expert Opin. Pharmacother., 9, 267-283 (2008). (Pubitemid 351233734)
23. Walsh, F., Willcock, J., and Amyes, S., High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J. Antimicrob. Chemother., 52, 345-353 (2003). (Pubitemid 37120710)
24. Weiss, K., Guilbault, C., Cortes, L., Restieri, C., Low, D. E., and the EQUERE project (Etude QUEbecoise des pathogènes REspiratoires), Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J. Antimicrob. Chemother., 50, 403-406 (2002).
25. Wolter, N., Smith, A. M., Farrell, D. J., Northwood, J. B., Douthwaite, S., and Klugman, K. P., Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation. Antimicrob. Agents Chemother., 52, 435-440 (2008). (Pubitemid 351170810)
26. Zuker, M., Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res., 31, 3406-3415 (2003). (Pubitemid 37442169)